AMBBY saw its Momentum Indicator move below the 0 level on December 12, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned negative. In of the 74 cases, the stock moved further down in the following days. The odds of a decline are at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where AMBBY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 50-day moving average for AMBBY moved below the 200-day moving average on November 26, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for AMBBY entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for AMBBY just turned positive on December 04, 2024. Looking at past instances where AMBBY's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
AMBBY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMBBY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.171) is normal, around the industry mean (23.300). AMBBY has a moderately high P/E Ratio (277.778) as compared to the industry average of (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.003) settles around the average of (0.018) among similar stocks. P/S Ratio (5.447) is also within normal values, averaging (43.338).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMBBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICEVX | 38.83 | -0.07 | -0.18% |
NYLI Epoch International Choice Class A | |||
NRERX | 14.32 | -0.05 | -0.37% |
Neuberger Berman Real Estate R3 | |||
OEICX | 89.73 | -0.35 | -0.39% |
JPMorgan Equity Index C | |||
VMNVX | 32.29 | -0.13 | -0.40% |
Vanguard Global Minimum Volatility Admr | |||
JETAX | 14.70 | -0.09 | -0.61% |
abrdn Global Equity Impact A |
A.I.dvisor tells us that AMBBY and AZTA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMBBY and AZTA's prices will move in lockstep.
Ticker / NAME | Correlation To AMBBY | 1D Price Change % | ||
---|---|---|---|---|
AMBBY | 100% | N/A | ||
AZTA - AMBBY | 24% Poorly correlated | +4.09% | ||
CLPBY - AMBBY | 23% Poorly correlated | -1.90% | ||
GNNDY - AMBBY | 23% Poorly correlated | -3.35% | ||
ALGN - AMBBY | 23% Poorly correlated | -0.56% | ||
VTAK - AMBBY | 21% Poorly correlated | -3.45% | ||
More |